Compare WAT & BIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WAT | BIP |
|---|---|---|
| Founded | 1958 | 2007 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Marine Transportation |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.4B | 16.4B |
| IPO Year | 1995 | 2008 |
| Metric | WAT | BIP |
|---|---|---|
| Price | $396.06 | $35.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 5 |
| Target Price | ★ $382.14 | $42.20 |
| AVG Volume (30 Days) | ★ 553.7K | 538.2K |
| Earning Date | 11-04-2025 | 11-07-2025 |
| Dividend Yield | N/A | ★ 4.80% |
| EPS Growth | ★ 3.82 | N/A |
| EPS | ★ 10.88 | 0.70 |
| Revenue | $3,105,638,000.00 | ★ $22,240,000,000.00 |
| Revenue This Year | $7.96 | N/A |
| Revenue Next Year | $6.32 | N/A |
| P/E Ratio | ★ $36.44 | $51.06 |
| Revenue Growth | 6.90 | ★ 8.14 |
| 52 Week Low | $275.05 | $25.72 |
| 52 Week High | $423.56 | $36.58 |
| Indicator | WAT | BIP |
|---|---|---|
| Relative Strength Index (RSI) | 63.00 | 55.38 |
| Support Level | $386.09 | $35.32 |
| Resistance Level | $403.80 | $36.58 |
| Average True Range (ATR) | 9.63 | 0.59 |
| MACD | -1.56 | -0.02 |
| Stochastic Oscillator | 57.37 | 53.85 |
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.
Brookfield Infrastructure Partners LP is a Bermuda exempted limited partnership that owns and operates quality, long-life assets that generate stable cash flows, by virtue of barriers to entry or other characteristics that tend to appreciate in value over time. It focuses on acquiring infrastructure assets that have low maintenance capital costs and high barriers to entry. The company's segments consist of Utilities, Transport, Midstream, and Data. Geographically, it generates maximum revenue from USA and also has a presence in Australia, Colombia, United Kingdom, Brazil, United States of America, Chile, Peru, and other countries.